A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Biomerica Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 800 shares of BMRA stock, worth $352. This represents 0.0% of its overall portfolio holdings.

Number of Shares
800
Holding current value
$352
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.82 - $1.29 $29,016 - $45,647
35,386 New
35,386 $29,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.87 $18,088 - $30,200
16,150 Added 58.49%
43,760 $59,000
Q1 2023

May 15, 2023

SELL
$1.86 - $3.56 $34,806 - $66,618
-18,713 Reduced 40.4%
27,610 $51,000
Q4 2022

Feb 14, 2023

BUY
$3.04 - $4.17 $105,436 - $144,628
34,683 Added 297.96%
46,323 $155,000
Q3 2022

Nov 14, 2022

SELL
$2.61 - $3.78 $4,742 - $6,868
-1,817 Reduced 13.5%
11,640 $46,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $4.69 $52,253 - $90,765
-19,353 Reduced 58.99%
13,457 $39,000
Q1 2022

May 16, 2022

BUY
$3.59 - $4.64 $53,982 - $69,771
15,037 Added 84.61%
32,810 $147,000
Q2 2021

Aug 16, 2021

BUY
$3.41 - $5.9 $60,605 - $104,860
17,773 New
17,773 $71,000
Q2 2019

Aug 14, 2019

SELL
$2.19 - $2.7 $24,626 - $30,361
-11,245 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$1.92 - $2.85 $21,590 - $32,048
11,245 New
11,245 $0

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $5.91M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.